Datwyler: Growth in Chinese healthcare market
Datwyler has signed a contract to acquire the Chinese company Yantai Xinhui Packing Co. Ltd. The Swiss group that this strategically important acquisition will provide direct access to the rapidly growing healthcare market in China. Closing is expected for Q1 2022.
“Yantai Xinhui Packing boasts high technological standards in its production. By applying our additional core competencies in solutions design and materials expertise, we are creating an optimal platform to accelerate growth in the Chinese market,” says Datwyler CEO Dirk Lambrecht.
“I’m delighted that Yantai Xinhui Packing will become part of the globally active Datwyler company. With Datwyler’s many years of experience and expertise, we can benefit even more from the growth of the Chinese healthcare market in the future," says Liu Xin, CEO of Yantai Xinhui Packing.
Family-owned Yantai Xinhui Packing was founded in 2003. In 2017, the company invested in building a new production plant in Shandong province in northeastern China. Yantai Xinhui Packing has automated production facilities for elastomer components for the healthcare market, its own development department and its own compounding facility. The company’s main products are butyl rubber stopper and polyisoprene rubber gaskets. With approx. 170 employees, the company has annual revenue of some CHF 15 million. The current management will remain in place. When integrating Yantai Xinhui Packing, Datwyler can draw on its many years of experience with its own Chinese plants for the automotive and industrial markets with some 1’500 employees in China.
China is the biggest emerging market for pharmaceuticals and already the second largest national pharmaceutical market in the world after the USA. Based on the revenue potential of its approximately 1.4 billion people, Datwyler expects the relevant healthcare market in China to grow above 10 % over the next few years.